Aripiprazole Injection Suppliers & Bulk Manufacturers
Available Forms: Intramuscular (IM) Injection
Available Strengths: Short-acting: 9.75 mg/1.3 mL; Long-acting: 300 mg, 400 mg (monthly)
Reference Brands: Abilify(EU & US)
Category:
Antipsychotropic Drugs
Aripiprazole, marketed as Abilify, is a widely used antipsychotic available in oral and injectable forms across the US and EU. Offered in strengths from 2 mg to 400 mg, it supports schizophrenia and bipolar treatment. Pharma buyers source aripiprazole in bulk from certified suppliers for mental health distribution channels.
Aripiprazole Injection is available in Intramuscular (IM) Injection
and strengths such as Short-acting: 9.75 mg/1.3 mL; Long-acting: 300 mg, 400 mg (monthly).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Aripiprazole Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Aripiprazole Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Aripiprazole is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, depression adjunct, and autism-related irritability. It is available in multiple dosage forms including oral tablets (2–30 mg), orally disintegrating tablets, oral solution (1 mg/mL), and IM injections (short and long-acting). Brands like Abilify and Abilify Maintena are widely marketed in the US and EU. Long-acting injectable forms (300 mg, 400 mg) are particularly preferred in maintenance therapy. Pharmaceutical distributors and bulk buyers source aripiprazole in various formulations for hospital use, psychiatric facilities, and retail pharmacy networks. Reliable GMP-compliant manufacturers offer consistent global B2B supply.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing